Cargando…

Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors

BACKGROUND: Hepatic metastases develop in approximately 50% of colorectal cancer (CRC) cases. We performed a review and meta-analysis to evaluate survival after resection of CRC liver metastases (CLMs) and estimated the summary effect for seven prognostic factors. METHODS: Studies published between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanas, Gena P, Taylor, Aliki, Primrose, John N, Langeberg, Wendy J, Kelsh, Michael A, Mowat, Fionna S, Alexander, Dominik D, Choti, Michael A, Poston, Graeme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496330/ https://www.ncbi.nlm.nih.gov/pubmed/23152705 http://dx.doi.org/10.2147/CLEP.S34285

Ejemplares similares

Use of electronic medical records in oncology outcomes research
por: Kanas, Gena, et al.
Publicado: (2010)

Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies
por: Simmonds, P C, et al.
Publicado: (2006)

The Prognostic Significance of the Preoperative Full Blood Count after Resection of Colorectal Liver Metastases
por: Dajani, K., et al.
Publicado: (2009)

Treatment of Advanced/Metastatic Melanoma in the United States and Western Europe: Results of the CancerMPact Survey
por: Hawthorne, Stephanie, et al.
Publicado: (2020)

Use of electronic medical records (EMR) for oncology outcomes research: assessing the comparability of EMR information to patient registry and health claims data
por: Lau, Edmund C, et al.
Publicado: (2011)

Domestic Asbestos Exposure: A Review of Epidemiologic and Exposure Data
por: Goswami, Emily, et al.
Publicado: (2013)

Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients
por: Arhin, Nina D., et al.
Publicado: (2021)

Patterns of Care and Outcomes for Non-Metastatic Prostate Cancer in the United States: Results of the CancerMPact(®) Survey 2018
por: de Sá Moreira, Eloisa, et al.
Publicado: (2021)

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
por: Schirripa, M, et al.
Publicado: (2015)

Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis
por: Bylsma, Lauren C., et al.
Publicado: (2019)

Factors affecting receipt of chemotherapy in women with breast cancer
por: Morimoto, Libby, et al.
Publicado: (2010)

Comments on Vimercati et al., 2019, “Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (southern Italy) mesothelioma register”
por: Mezei, Gabor, et al.
Publicado: (2019)

Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis
por: Mezei, Gabor, et al.
Publicado: (2021)

Influence of primary tumor location and resection on survival in metastatic colorectal cancer
por: Tharin, Zoé, et al.
Publicado: (2020)

T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases
por: Pugh, Siân A, et al.
Publicado: (2014)

The beneficial effect of palliative resection in metastatic colorectal cancer
por: Park, J H, et al.
Publicado: (2013)

Time‐dependent and nonlinear effects of prognostic factors in nonmetastatic colorectal cancer
por: Chi, Sheng‐Qiang, et al.
Publicado: (2017)

Retrospective analysis of KRAS status in metastatic colorectal cancer patients: a single-center feasibility study
por: Montomoli, Jonathan, et al.
Publicado: (2012)

Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)
por: Lehtomäki, Kaisa, et al.
Publicado: (2023)

Efficacy of Primary Tumor Resection in Metastatic Colorectal Cancer
por: Huang, Yong, et al.
Publicado: (2020)

Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival
por: Homayounfar, K., et al.
Publicado: (2013)

Prognostic value of regional lymph node involvement in patients with metastatic colorectal cancer: palliative versus curative resection
por: Kuo, Ya-Ting, et al.
Publicado: (2021)

Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score (mCCS)
por: Marschner, N., et al.
Publicado: (2019)

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
por: Nordlinger, Bernard, et al.
Publicado: (2008)

Cadherin–catenin expression in primary colorectal cancer: a survival analysis
por: Hugh, T J, et al.
Publicado: (1999)

Lymph node status as a prognostic factor after palliative resection of primary tumor for patients with metastatic colorectal cancer
por: Li, Qingguo, et al.
Publicado: (2017)

Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
por: Ergun, Yakup, et al.
Publicado: (2020)

Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases
por: Evrard, Serge, et al.
Publicado: (2014)

Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306
por: Modest, Dominik Paul, et al.
Publicado: (2020)

A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database
por: Kong, Xiangxing, et al.
Publicado: (2018)

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
por: Matthews, LH McCormick, et al.
Publicado: (2015)

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
por: Souglakos, J, et al.
Publicado: (2009)

Surgery for colorectal liver metastases
por: Primrose, J N
Publicado: (2010)

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
por: McCormick Matthews, L H, et al.
Publicado: (2015)

Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection
por: Ghiringhelli, Francois, et al.
Publicado: (2014)

Progressive Oncological Surgery Is Associated with Increased Curative Resection Rates and Improved Survival in Metastatic Colorectal Cancer
por: Primavesi, Florian, et al.
Publicado: (2019)

Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer
por: Yang, Yi, et al.
Publicado: (2020)

Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis
por: Cao, Dedong, et al.
Publicado: (2019)

Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer
por: Lee, Sookyung, et al.
Publicado: (2016)

Prognostic factors of survival and a new scoring system for liver resection of colorectal liver metastasis
por: Cheng, Kai-Chi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_thoh5qf2v8fcigv199tbop4nnp